Lombard Medical is a global medical technology company focused on providing innovative endovascular products which broaden clinicians’ treatment options and opportunities for treating more patients safely and more effectively with Endovascular Aortic Repair (EVAR).
Our talented teams are dedicated to delivering innovation in EVAR by incorporating the advice and experience of clinicians and then developing total solutions that go beyond the products themselves.
Aorfix™ Endovascular Stent Graft
As the understanding of Abdominal Aortic Aneurysm (AAA) treatment advances, stent graft technologies are progressing to meet a greater clinical need for flexibility and adaptability to varying anatomies. The Aorfix™ Endovascular Stent Graft has been designed, in collaboration with world renowned EVAR specialists, with the aim of giving the choice back to the experts by expanding the scope of anatomies treated by EVAR. Aorfix™ is the only endovascular stent graft in the world with FDA approval to treat aortic neck angulations of 0° to 90°.
This exclusive approval to treat even the most tortuous anatomies was gained following rigorous investigations and analysis of clinical data collected for over 5 years to complete an IDE trial in the US. With over 4,000 cases completed to date using Aorfix™ worldwide, it is fast becoming the most trusted stent graft in treating a wider range of anatomies.
Specialists Enabling Experts
Tortuous anatomy is a concerning and unique challenge in the treatment of AAA disease with EVAR. It is reported that 20-30% of patients suffering from AAA disease present with complex anatomies, either at the top (neck) of the aneurysm or in the iliac arteries.
Aorfix™ is specifically designed to allow clinicians to expand the reach of their practice to include this important segment of the population.
Unchanged in design principle since conception in 2001, this unique stent graft has a circular wire structure and microfiber multifilament weaving to give it unrivalled flexibility and conformability over time.